Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes. - Wikidata - awgldk - TriplyDB

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.

http://www.wikidata.org/entity/Q38979626

about

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis.Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool.Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience.Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

P2860

Q30275673-89030604-88E4-46CC-B8C4-2FB7055D7044 Q30275728-315DD8B0-9CAB-48C9-A60B-B812B8524D16 Q33621748-E898E420-843E-44B0-B425-7CB39CEE653F Q36540893-736DEAEE-B993-4D4D-AF67-30FDFC9B8859 Q36540925-96DFA80E-1FD2-47C9-82C8-BE8EB950FF54 Q36644647-AAE10E74-1E10-4E52-826D-75502CF44163 Q36730088-1EB6E0A7-8735-43DF-B793-AD81BC307DE0 Q36869913-3F591533-B4F7-4899-86D1-CE4AC6DAFB16 Q36887811-93B35616-7C21-46E5-A15F-6ACC0FEB5B8E Q36933441-3750245F-2BF2-4767-9C6A-F658B35EED60 Q37120152-DF7D1209-7697-435C-8BA5-038A58F36A02 Q37287787-2C91C203-4758-44D1-9907-0A591F6EF4B2 Q37287830-C52DD60E-898F-4C62-A6E3-331871F802C0 Q37339287-90199085-AED4-4B50-8381-94C6329C8C60 Q37339290-A93E3497-FAE1-4FDF-A1CF-A6A994C28127 Q37339294-4520F9F4-D7A7-4E0D-B5ED-09599A5DB0E1 Q38557282-106C9F28-A2D1-4426-A18A-AFB5087DF4F3 Q38979629-5F2FADC7-A924-45A9-93DB-F4BC21CB558F Q40065397-49F5D020-7B7C-4BED-9BF1-6B6EC7897896 Q40139991-CF0F3F3C-19E1-48A5-9E26-3F77CC7650E2 Q40184248-281E7541-84C5-41D1-B5A5-84DDF720E291 Q40211670-FEFCFA55-F1AB-48DA-A2FA-61C62AF8FD40 Q40679730-A30E7A9E-3AFF-443E-9B39-7BCBA73E8D2F Q41082086-E2931EDB-B94E-4C35-9F92-B8A481028207 Q41695565-98B4BF76-D9DA-49E7-943C-BC50D9343B11 Q41996871-048AC67F-B3DF-45B2-9F28-B96F00B7BC24 Q46427262-681CAE50-5DF1-46E5-A20D-153A2A241F64

P2860

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.

http://www.wikidata.org/entity/Q38979626

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Forecasting Accuracy of the Ho ...... Clinical Therapeutic Outcomes.

@en

type

label

Forecasting Accuracy of the Ho ...... Clinical Therapeutic Outcomes.

@en

prefLabel

Forecasting Accuracy of the Ho ...... Clinical Therapeutic Outcomes.

@en

P1433

Q38979626-789AB438-D4AC-4F74-8C3E-3CB26A9F8F5E

P1476

Q38979626-B6495C38-55AE-4FF8-B57C-2B9907A59B1B

P2093

Q38979626-1D69DDC9-8C7A-44BE-86E0-02FAD7F62BCC

Q38979626-4B1BA719-6395-40B2-8DFA-C441CD4E86F9

Q38979626-D078125E-CBD6-41D5-9F2F-F83142655D6B

Q38979626-F24AD65B-5622-466F-9A25-6CF3995A0B23

P2860

Q38979626-05F704ED-0E76-4CF6-856F-EF602C0C4935

Q38979626-0DF46ADC-49AF-4A12-BC38-0A317FFEC043

Q38979626-172B1597-5622-4CEB-88B4-7E2A33CF5E61

Q38979626-285A3CA0-7EF1-4980-BC74-CDFBEF16EF70

Q38979626-28F3FF42-993A-491D-9831-CAFD617BE6A7

Q38979626-2963BD37-E497-4AC4-B9C9-7181443F164D

Q38979626-3155DA23-8019-406C-9925-7F0EF7892C4B

Q38979626-3ABCB26A-D48D-4B9F-A7C1-486914A85779

Q38979626-3F75647D-5482-4E1A-A312-32D2D59F6F1F

Q38979626-47EE6E23-E27C-4551-8E69-69CC5BAFAA17

P304

Q38979626-75103952-8593-417D-A112-637A1D474BD3

P31

Q38979626-960CACC4-D81E-44A9-B508-5BC34CEBEE7E

P356

Q38979626-7C28C9A0-0EC3-4536-A322-7A7FA807D084

P407

Q38979626-E544F0F8-9694-4AA8-BA82-7369C7872768

P478

Q38979626-D75F2A74-C697-4FA6-BAC1-7C598A4F5F6A

P50

Q38979626-593CB07A-8C10-4BA0-80D3-6A805225EA64

P577

Q38979626-F1FC5380-67F0-49DA-999F-E76322BF312F

P5875

Q38979626-687C8580-F00F-40CB-9059-F65F997EFA96

P698

Q38979626-CD671E21-BF5C-444E-AA9F-2D7F444B9579

P921

Q38979626-AA9DFB83-4E4E-4430-8FBF-9C58C9A92CD4

P356

P1433

Clinical Infectious Diseases

P1476

Forecasting Accuracy of the Ho ...... Clinical Therapeutic Outcomes.

@en

P2093

Debra Hanna

http://www.w3.org/2001/XMLSchema#string

Eric Nuermberger

http://www.w3.org/2001/XMLSchema#string

Jotam G Pasipanodya

http://www.w3.org/2001/XMLSchema#string

Klaus Romero

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis

Global transcriptional profiling of longitudinal clinical isolates of Mycobacterium tuberculosis exhibiting rapid accumulation of drug resistance

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

The pyrazinamide susceptibility breakpoint above which combination therapy fails.

Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy.

A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients

Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.

P304

S25-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV427

http://www.w3.org/2001/XMLSchema#string

P407

P478

61 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280584843

http://www.w3.org/2001/XMLSchema#string

P698

26224769

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde